Track the Citi Pharma Ltd. share price and the full insider trade history of the company, a listed issuer based in Pakistan. Shares are listed on the PK market, under the oversight of PSX (SECP). Market capitalisation: €437bn. The latest transaction was filed on 10 August 2026. The full history is openly available.
31
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Citi Pharma Ltd. Strong Buy (bullish), based on 10 analysts. Average price target: CN¥38.10.
Fundamental score
Ranked 687 of 29,064 companies
83.2
score / 100
Value
84
Quality
83
FCF yld17%
Earn yld6.9%
EV/EBITDA·
ROE12%
Gross mgn·
Net mgn40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.